期刊文献+

国际药品不良反应公众报告现状的分析与思考 被引量:4

Analysis and Reflection on the Current Situation of International Public Reporting of Adverse Drug Reactions
下载PDF
导出
摘要 我国已经建立较为完善的药品不良反应监测体系,并鼓励公众主动报告不良反应,但历年来公众报告数量很少。本文分析了国际发达国家,主要是美国、加拿大、澳大利亚和英国药品不良反应公众报告的现状,总结了在法律法规、报告途径、报告表格设计等方面的模式,为我国建立药品不良反应公众报告模式提供参考。 A relatively perfect adverse drug reactions monitoring system has been established in China. The public was encouraged to report adverse drug reactions in our country while the number of the public reports was very small over the years. To provide reference for the establishment of public reporting model of adverse drug reactions in China, current situations of the public reporting of adverse drug reactions in the developed countries mainly including the United States, Canada, Australia and the UK was analyzed, and the laws and regulations, the reporting ways and the reporting forms were summarized.
出处 《中国药物警戒》 2017年第7期419-423,429,共6页 Chinese Journal of Pharmacovigilance
基金 国家食品药品监督管理总局药品评价中心课题:我国公众药械化妆品不良反应报告模式研究
关键词 国际 药品不良反应监测 自发报告 公众报告 international adverse drug reactions monitoring spontaneous reporting public reporting
  • 相关文献

参考文献5

二级参考文献50

  • 1马烨,赵德才,臧春鹏,于兰,赵燕,文毅,张福杰.应用特尔菲法确定我国艾滋病抗病毒药物治疗监管评价指标[J].中华全科医师杂志,2006,5(11):664-668. 被引量:7
  • 2方素清.论英国黄卡制度对我国药品不良反应监测的启示[J].国际医药卫生导报,2006,12(23):100-102. 被引量:12
  • 3孔庆衍,周勇,田月洁,黄传海,谢彦军.山东省药品不良反应监测状况调查[J].中国药物警戒,2007,4(3):146-150. 被引量:9
  • 4田小权,李先兰.药品经营企业药学技术人员药品不良反应认知度调查分析[J].中国药物警戒,2007,4(3):151-153. 被引量:5
  • 5EMA. EMA.New Pharmacovigilance Legislation: Update on im- plementation[EB/OL].[2013-5-1].http://www.ema.europa.eu/docs/ en_GB/document_library/Presentation/2012/02/WC500122162.pdf.
  • 6MHRA.The New PV Legislation Perspective from a Member State [EB/OL]. [2013-5-1 ].http://www.ema.europa.eu/docs/en_GB/ document_library/Presentation/2011/06/WC500107889.pdf.
  • 7EMA. 2010 pharmacovigilance legislation [EB/OL]. [2013-5-1]. http://www.ema.europa.eu/ema/index.j sp ?curl=pages/regulation/ general/general_content 000492 .j sp&mid=WC0b01 ac058033e8ad.
  • 8EMA. Project 00305: Implementation of the new Pharmacovigilance legislation[EB/OL]. [2013-5-1 ]. http://www.ema.europa.eu/ema/ pages/includes/document/open_document .j sp ?webContentld= WCS00105351European Medicines Agency and Member States Joint Implementation Check-list.
  • 9EMA.Electronic submission of information on medicines [EB/OL] [2013-5-1].http://www.ema.europa.eu/ema/index.j sp?curl=pages/ regulation/general/general_content_000496j sp&mid=WC0b01 ac 058058f329.
  • 10EMA. Countdown to July 2012: the establishment and functioning of the PRAC[EB/OL].[2013-5-1].http:/Iwww.ema.europa.eu/docs/ en_GB/document_library/Other/2012/07/WC500129301 .pdf.

共引文献45

同被引文献38

引证文献4

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部